38296 Federal Register / Vol. 77, No. 124 / Wednesday, June 27, 2012 / Notices 

ANNUALIZED BURDEN TABLE—Continued 

Questionnaire 

(respondent) 

Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden per 

respondent 

in hours 

Total burden 

in hours 

Family Core (adult family member) ................................................................. 55,000 1 23/60 21,083 

Adult Core (sample adult) ................................................................................ 44,000 1 15/60 11,000 

Child Core (adult family member) .................................................................... 17,000 1 10/60 2,833 

Child/Teen Record Check (medical provider) ................................................. 10,000 1 5/60 833 

Supplements (adult family member) ................................................................ 60,000 1 12/60 12,000 

Multi-mode study (adult family Member) ......................................................... 5,000 1 30/60 2,500 

Reinterview Survey .......................................................................................... 5,000 1 5/60 417 

Total Burden Hours .................................................................................. ........................ ........................ ........................ 51,666 

Dated: June 21, 2012. 

Ron A. Otten, 

Director, Office of Scientific Integrity, Office 

of the Associate Director for Science (OADS), 

Office of the Director, Centers for Disease 

Control and Prevention. 

[FR Doc. 2012–15749 Filed 6–26–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2012–0004] 

Draft Public Health Action Plan—A 

National Public Health Action Plan for 

the Detection, Prevention, and 

Management of Infertility 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Extension of public comment 

period. 

SUMMARY: On May 16, 2012, the Centers 

for Disease Control and Prevention 

(CDC), located within the Department of 

Health and Human Services (HHS) 

published a notice in the Federal 

Register requesting public comment on 

the draft National Public Health Action 

Plan for the Detection, Prevention, and 

Management of Infertility (77 FR 28883). 

Written and electronic comments were 

to be received on or before June 15, 

2012. HHS/CDC has received a request 

asking for a 30 day extension of the 

comment period. In consideration of 

this request, HHS/CDC is extending the 

comment period to July 16, 2012. 

DATES: Written comments must be 

received on or before July 16, 2012. 

Please refer to SUPPLEMENTARY

INFORMATION for additional information. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2012– 

0004 by any of the following methods: 

Internet: Access the Federal 

eRulemaking portal at http:// 

www.regulations.gov. Follow the 

instructions for submitting comments. 

Mail: Centers for Disease Control and 

Prevention, National Center for Chronic 

Disease Prevention and Health 

Promotion, Division of Reproductive 

Health, Attn: National Public Health 

Action Plan for the Detection, 

Prevention, and Management of 

Infertility, Docket No. CDC–2012–0004, 

4770 Buford Highway NE., Mailstop K– 

34, Atlanta, Georgia 30341. 

All relevant comments received will 

be posted publicly without change, 

including any personal or proprietary 

information provided. To download an 

electronic version of the plan, please 

access http://www.regulations.gov. 

Written comments, identified by 

Docket No. CDC–2012–0004, will be 

available for public inspection Monday 

through Friday, except for legal 

holidays, from 9 a.m. until 5 p.m., 

Eastern Daylight Time, at 2900 

Woodcock Blvd., Atlanta, Georgia 

30341. Please call ahead to (770) 488– 

5200 and ask for a representative from 

the Division of Reproductive Health to 

schedule your visit. Comments may also 

be viewed at www.regulations.gov. 

FOR FURTHER INFORMATION CONTACT: 

Denise Jamieson, Centers for Disease 

Control and Prevention, National Center 

for Chronic Disease Prevention and 

Health Promotion, Division of 

Reproductive Health, 4770 Buford 

Highway NE., Mailstop K–34, Atlanta, 

Georgia 30341, (770) 488–5200. 

SUPPLEMENTARY INFORMATION: In 2007, a 

CDC-wide ad hoc workgroup formed to 

examine the full scope of infertility 

activities across the agency. This 

workgroup conducted an assessment to 

identify gaps and opportunities in 

public health surveillance, research, 

communications, programs, and policy 

development, which led to the 2010 

publication of a white paper outlining 

the need for a national plan, with a 

public health focus, on infertility 

prevention, detection, and management. 

In consultation with many 

governmental and nongovernmental 

partners, CDC developed the National 

Public Health Action Plan for the 

Detection, Prevention and Management 

of Infertility. Addressing both male and 

female infertility, the plan outlines and 

summarizes actions needed to promote, 

preserve, and restore the ability of 

women in the United States to conceive, 

carry a pregnancy to term, and deliver 

a healthy infant. This goal extends 

beyond simply addressing the inability 

to conceive but also focuses on reducing 

the burden of impaired fecundity by 

promoting behaviors that maintain 

fertility; by promoting prevention, early 

detection, and treatment of medical 

conditions; and by reducing 

environmental and occupational threats 

to fertility. Given the public health 

focus of this action plan, promoting 

healthy pregnancy outcomes associated 

with treating and managing infertility is 

also important, as is improving the 

efficacy and safety of infertility 

treatment. 

The document is organized into three 

chapters: ‘‘Detection of Infertility,’’ 

‘‘Prevention of Infertility,’’ and 

‘‘Management of Infertility.’’ Each 

chapter addresses the topic’s public 

health importance, existing challenges, 

and opportunities for action to decrease 

the impact of infertility on the public’s 

health. The suggested opportunities 

provide federal and other government 

agencies, professional and consumer 

organizations, and other partners and 

stakeholders a foundation and platform 

to work together to decrease the burden 

of infertility in the United States. 

Since the draft plan was published on 

May 16, 2012, HHS/CDC has received a 

request to extend the comment period 

by an additional 30 days. HHS/CDC is 

committed to affording the public a 

meaningful opportunity to comment on 

the draft plan and welcomes comments. 


srobinson on DSK4SPTVN1PROD with NOTICES
Federal Register / Vol. 77, No. 124 / Wednesday, June 27, 2012 / Notices 38297 

HHS/CDC has posted the original 

notice and all related materials on 

www.regulations.gov. 

Dated: June 20, 2012. 

Kathleen Sebelius, 

Secretary, Department of Health and Human 

Services. 

[FR Doc. 2012–15642 Filed 6–26–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket Number NIOSH–033–A] 

Revised Document Posted: NIOSH List 

of Antineoplastic and Other Hazardous 

Drugs in Healthcare Settings 2012 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC), 

Department of Health and Human 

Services (HHS). 

ACTION: Notice of issuance of Final 

Guidance Publication. 

SUMMARY: The National Institute for 

Occupational Safety and Health 

(NIOSH) of the Centers for Disease 

Control and Prevention (CDC) 

announces the publication of the 

following document entitled ‘‘NIOSH 

List of Antineoplastic and Other 

Hazardous Drugs in Healthcare Settings 

2012.’’ NIOSH is making available a 

copy of Appendix A at http:// 

www.cdc.gov/niosh/docs/2012-150. 

Background: The NIOSH Alert: 

NIOSH published Preventing 

Occupational Exposures to 

Antineoplastic and Other Hazardous 

Drugs in Health Care Settings in 

September 2004 (http://www.cdc.gov/ 

niosh/docs/2004-165/). Appendix A of 

this Alert defined hazardous drugs and 

provided a list of drugs that were 

considered hazardous and required 

special handling. In 2010, NIOSH 

published an update to this list 

(http://www.cdc.gov/niosh/docs/2010- 

167/). Since publishing the 2010 update 

to the list, NIOSH reviewed 

approximately 70 new drugs that 

received FDA approval and 

approximately 180 drugs that received 

new special warnings (usually black box 

warnings) based on reported adverse 

effects in patients covering the time 

period from October 2007 to December 

2009. From this list of approximately 

250 drugs, NIOSH determined 26 drugs 

to have one or more characteristics of a 

hazardous drug. In addition, NIOSH 

removed 15 drugs from the 2012 list 

because they did not meet the NIOSH 

definition, were no longer available in 

the U.S or were regulated by other 

government entities. NIOSH published 

this preliminary list for comment in 

NIOSH Docket Number 190. 

After expert panel review, public 

review and comment, and review of the 

scientific literature, NIOSH has 

developed a revised list of hazardous 

drugs. Along with drugs initially 

identified in the 2010 Hazardous Drug 

List, NIOSH is adding a total of 26 new 

drugs to the 2012 NIOSH List of 

Hazardous Drugs and is deleting 15 

drugs. 

This guidance document does not 

have the force and effect of law. 

FOR FURTHER INFORMATION CONTACT: 

Barbara MacKenzie, NIOSH, Robert A. 

Taft Laboratories, 4676 Columbia 

Parkway, MS–C26, Cincinnati, OH 

45226, Telephone (513) 533–8132, email 

hazardousdrugs@cdc.gov. 

Dated: June 20, 2012. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health, Centers for Disease Control 

and Prevention. 

[FR Doc. 2012–15651 Filed 6–26–12; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier CMS–359 and –360] 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS) is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Extension without change of a 

currently approved collection. Title of 

Information Collection: Comprehensive 

Outpatient Rehabilitation Facility 

(CORF) Eligibility and Survey Forms. 

Use: CMS–359 serves as the application 

for facilities wishing to participate in 

the Medicare/Medicaid program as 

CORFs. The form initiates the process 

for obtaining a decision as to whether 

the conditions of participation are met. 

It also promotes data reduction (key 

punching) or introduction to and 

retrieval from the Medicare/Medicaid 

Automated Certification System, 

ASPEN, by the CMS Regional Offices 

(ROs). Should any question arise 

regarding the structure of the 

organization, this information is readily 

available without going through the 

process of completing the form again. 

CMS–360 is used by the State survey 

agency to record data collected to 

determine provider compliance with 

individual conditions of participation 

and to report it to the Federal 

government. CMS has the responsibility 

and authority for certification decisions 

which are based on provider 

compliance with the conditions of 

participation. The information needed 

to make these decisions is available to 

CMS only through use of information 

abstracted from the survey checklists. 

The form is primarily a worksheet 

designed to facilitate keypunching into 

the ASPEN by the State Agency after the 

survey is completed. 

Form Number: CMS–359 (CORF 

Eligibility Form) and CMS–360 (CORF 

Survey Report Form); OCN 0938–0267. 

Frequency: Occasionally. Affected 

Public: Private Sector (Business or other 

for-profits). Number of Respondents: 

295. Total Annual Responses: 42. Total 

Annual Hours: 137. (For policy 

questions regarding this collection 

contact Georgia Johnson at 410–786– 

6859. For all other issues call 410–786– 

1326.) 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS’ Web Site 

address at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or 

Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786– 

1326. 

In commenting on the proposed 

information collections please reference 

the document identifier or OMB control 

number. To be assured consideration, 

comments and recommendations must 


srobinson on DSK4SPTVN1PROD with NOTICES